Long-term use of angiotensin II receptor antagonists and calcium-channel antagonists in Algerian hypertensive patients: Effects on metabolic and oxidative parameters

被引:9
|
作者
El Hassar, Chafika [1 ]
Merzouk, Hafida [1 ]
Merzouk, Sid Ahmed [2 ]
Malti, Nassima [1 ]
Meziane, Abderrahim [3 ]
Narce, Michel [4 ]
机构
[1] Univ Abou Bekr Belkaid Tlemcen, Lab Physiol Physiopathol & Biochem Nutr, Dept Biol, Fac Nat & Life Sci, Tilimsen 13000, Algeria
[2] Univ Abou Bekr Belkaid Tlemcen, Fac Engn, Dept Tech Sci, Tilimsen 13000, Algeria
[3] Tlemcen Univ Hosp Ctr, Dept Cardiol, Tilimsen 13000, Algeria
[4] Univ Burgundy, Fac Life Earth & Environm Sci, INSERM UMR 866, F-21000 Dijon, France
关键词
Hypertension; Calcium antagonists; Angiotensin II receptor antagonists; Metabolism; Oxidative stress; Free radicals; ENDOTHELIAL DYSFUNCTION; NITRIC-OXIDE; STRESS; TELMISARTAN; PATHOGENESIS; RELEASE; LIPIDS;
D O I
10.1016/j.freeradbiomed.2014.12.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effects of calcium antagonists (amlodipine) and angiotensin II receptor antagonists (telmisartan) on lipid profile and oxidative markers were investigated in Algerian hypertensive patients. At the beginning and after 1 year of antihypertensive therapy, blood samples are collected for determination of biochemical parameters (glucose, cholesterol, triglycerides, urea, creatinine) and oxidative markers (malondialdehyde, carbonyl proteins, nitric oxide, superoxide anion, vitamin C, glutathione, catalase, superoxide dismutase). The results of this study indicate that telmisartan and amlodipine are effective antihypertensive agents in the treatment of hypertension because a significant reduction in systolic and diastolic blood pressure was observed in all hypertensive patients after 1 year of treatment. Our results show also that telmisartan and amlodipine treatments counteracted hypertension-dependent lipid abnormalities and oxidative stress. Telmisartan treatment appears to be more efficient than amlodipine treatment. In addition, telmisartan, which reversed all lipid and redox changes associated with hypertension, should be prescribed, especially in hypertensive patients with hypertriglyceridemia and with severe oxidative stress. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:147 / 153
页数:7
相关论文
共 50 条
  • [1] Hypertension and oxidant stress: Effects of angiotensin II receptor antagonists and calcium-channel antagonists on oxidant status in Algerian hypertensive men.
    Malti, N.
    El Hassar, C.
    Merzouk, H.
    Merzouk, S. A.
    Meziane, A.
    ACTA PHYSIOLOGICA, 2017, 221 : 162 - 162
  • [2] HORMONAL AND METABOLIC EFFECTS OF CALCIUM-CHANNEL ANTAGONISTS IN MAN
    SCHOEN, RE
    FRISHMAN, WH
    SHAMOON, H
    AMERICAN JOURNAL OF MEDICINE, 1988, 84 (03): : 492 - 504
  • [3] EFFECTS OF ANGIOTENSIN II RECEPTOR ANTAGONISTS AND CALCIUM CHANNEL BLOCKERS ON CARDIOVASCULAR NEURAL REGULATION IN HYPERTENSIVE PATIENTS DURING NAP SLEEP
    Ko, Li-Chin
    Yang, Cheryl C. H.
    Kuo, Terry B. J.
    Chern, Chang-Ming
    JOURNAL OF HYPERTENSION, 2016, 34 : E140 - E141
  • [4] Long-term treatment with angiotensin II receptor antagonists does no modify the ACTH-cortisol axis in hypertensive patients
    Segura, J
    Campo, C
    Albarrán, O
    Casal, MC
    Fernández, L
    Guerrero, L
    Vallejo, OG
    Ruilope, LM
    Robles, RG
    JOURNAL OF HYPERTENSION, 2002, 20 : S40 - S40
  • [5] Long-term effects of calcium antagonists on augmentation index in hypertensive patients with chronic kidney diseases
    Takenaka, Tsuneo
    Takane, Hiroshi
    Okada, Hirokazu
    Ohno, Yoichi
    Suzuki, Hiromichi
    CLINICAL KIDNEY JOURNAL, 2009, 2 (02): : 192 - 193
  • [6] Long-term effects of angiotensin II receptor blockers in hypertensive patients with chronic kidney disease and the metabolic syndrome
    Watanabe, H.
    Nakagawa, K.
    Kakihana, M.
    EUROPEAN HEART JOURNAL, 2011, 32 : 324 - 324
  • [7] The effects of replacing dihydropyridine calcium-channel blockers with angiotensin II receptor blocker on the quality of life of hypertensive patients
    Yamamoto, S
    Kawashima, T
    Kunitake, T
    Koide, S
    Fujimoto, H
    BLOOD PRESSURE, 2003, 12 : 22 - 28
  • [8] Assesment of albuminuria in hypertensive patients treated with angiotensin II receptor antagonists (ARB)
    Tudorica, C.
    Muraru, M.
    Spataru, D.
    Tudorica, S.
    Bruckner, I.
    JOURNAL OF HYPERTENSION, 2008, 26 : S521 - S521
  • [9] Spironolactone and Chlorthalidone in Uncontrolled Elderly Hypertensive Patients Treated with Calcium Antagonists and Angiotensin II Receptor-Blocker: Effects on Endothelial Function, Inflammation, and Oxidative Stress
    Yamanari, Hiroshi
    Nakamura, Kazufumi
    Miura, Daiji
    Yamanari, Shuichi
    Ohe, Tohru
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2009, 31 (07) : 585 - 594
  • [10] REVERSAL OF CARDIAC-HYPERTROPHY BY LONG-TERM TREATMENT WITH CALCIUM-ANTAGONISTS IN HYPERTENSIVE PATIENTS
    AGABITIROSEI, E
    MUIESAN, ML
    ROMANELLI, G
    BESCHI, M
    CASTELLANO, M
    MUIESAN, G
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1988, 12 : S75 - S78